Prime Movers Lab Fund I LP's Form 4 filing
Vaxxinity, Inc. (VAXX) · filed Dec 5, 2022
- Accession no.
- 0001062993-22-023345
- Filed
- Dec 5, 2022, 5:31 PM ET
- Trade date
- Dec 1-2, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.03M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prime Movers Lab Fund I LPCIK 0001751631 | 10% Owner |
| Sloss DakinCIK 0001875411 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Class A Common Stock | SSaleDisposed | −63,843 | $2.97F1 | −$189,722.24 | 2,163,122 | Indirect | |
| Dec 1, 2022 | Class A Common Stock | SSaleDisposed | −270,964 | $2.97F1 | −$805,223.72 | 9,180,710 | Direct | |
| Dec 2, 2022 | Class A Common Stock | SSaleDisposed | −2,620 | $2.57F4 | −$6,728.68 | 2,160,502 | Indirect | |
| Dec 2, 2022 | Class A Common Stock | SSaleDisposed | −11,121 | $2.57F4 | −$28,560.95 | 9,169,589 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price of $2.9717 per share represents a weighted average of purchase prices ranging from $3.38 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F4
The price of $2.5682 per share represents a weighted average of purchase prices ranging from $2.86 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 2 transactions in Table I.